Delivery Order SPE2DB24D2003-SPE2DB24FXGS7

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $6.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, with a ceiling value of $1,166.06 and a period of performance extending to June 23, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, is a Delivery Order valued at $2,785.90 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a prescription medication, to support various government healthcare programs and military treatment facilities. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of VYVANSE 50 MG CAPSULE 100S. The award has a ceiling value of $1,427.48 and is a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of January 16, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
The U.S. Defense Logistics Agency (DLA) awarded a $1,293.00 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the provision of 4565519574 - VYVANSE 50 MG CAPSULE 100S. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and...
This federal contract award to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $3,516.78, is for the delivery of 4,566,526,139 units of the pharmaceutical product VYVANSE 30 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,658.67, is a delivery order for the supply of VYVANSE 40 MG CAPSULE 100S, a prescription medication. The contract has a ceiling value of $1,658.67 and a period of performance through December 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYVANSE 40 MG CAPSULE 100S. The contract, valued at $3,339.12, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999, for the supply of a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,033.44 firm fixed-price delivery order is for the supply of VYVANSE 10 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of August 16, 2024 and was awarded on August 15, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,986.08, is for the delivery of VYVANSE 60 MG CAPSULE 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the Ultimate Completion Date is October 17, 2024. There is no set-aside designation indicated for this award. In addition to this specific...
This federal contract award, valued at $3,148.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication, with a completion date of October 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB24FXGS7
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical is for the supply of VYVANSE 50 MG CAPSULE 100S, a prescription medication, with a ceiling value of $6,503.14. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to procure a comprehensive range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation and is expected to be completed by September 10, 2024.

Generated 12/9/24, 1:51 PM